Science is enabling women to have children later in life as new technologies transform IVF success rates. But an increasingly globalised IVF trade also poses dangers.

Science is changing how and when families are made. Women are going to be able to have both career and family in a way that we’ve never seen before. New technologies are transforming IVF success rates. AI allows us to look at features of the embryo invisible to the human eye.

Dawn and her husband, Mike, who is 66 are proud first-time parents in Nova Scotia, Canada. They married in 1977 and tried for a baby for decades. Attempts to conceive naturally and to adopt failed. So five years ago Dawn turned to IVF and donor eggs for help.

In Canada, as in America, industry guidelines discourage embryo transfers to women over 55 who face a higher risk of prenatal health conditions including pre-eclampsia, hypertension and diabetes. Dawn considered surrogacy. She looked abroad to developing countries with less restrictive guidelines and legislation.

International fertility consultant, Crystal Travis directed the couple towards Georgia, one of the world’s least regulated fertility markets and one of the few countries that allows surrogates and donors of eggs and embryos to be paid. After medical tests, Dawn had an embryo made with a donor egg and donor sperm implanted.

The total number of fertility clinics around the world is estimated to have increased by almost 70% in the last ten years. The value of the global fertility industry is predicted to rise from $25bn today, to $41bn by 2026. Many believe there needs to be more regulation of an increasingly globalised IVF trade including Dr Danielle Lane, a fertility specialist based in San Francisco.